Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.710
+0.130 (5.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lisata Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 23 | 22 | 20 | 50 | 28 | 26 | |
| Market Cap Growth | 43.24% | 11.75% | -60.48% | 81.39% | 6.25% | -25.50% | |
| Enterprise Value | -13 | -32 | -55 | -50 | -12 | -2 | |
| Last Close Price | 2.71 | 2.73 | 2.53 | 12.62 | 21.45 | 37.65 | |
| PB Ratio | 0.67 | 0.46 | 0.30 | 0.55 | 0.86 | 1.27 | |
| P/TBV Ratio | 0.75 | 0.46 | 0.30 | 0.55 | 0.85 | 1.25 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | |
| Quick Ratio | 7.64 | 7.82 | 10.96 | 21.00 | 9.86 | 4.21 | |
| Current Ratio | 8.03 | 8.18 | 11.26 | 21.27 | 10.08 | 4.35 | |
| Return on Equity (ROE) | -48.15% | -36.49% | -68.50% | -44.21% | -30.84% | -66.72% | |
| Return on Assets (ROA) | -30.49% | -25.16% | -20.00% | -27.30% | -37.89% | -35.01% | |
| Return on Capital (ROIC) | -33.87% | -27.94% | -21.32% | -28.92% | -43.99% | -42.58% | |
| Earnings Yield | -91.16% | -93.79% | -272.69% | -54.59% | -29.38% | -74.17% | |
| FCF Yield | -83.06% | -90.15% | -107.90% | -44.33% | -31.88% | -72.33% | |
| Buyback Yield / Dilution | -3.19% | -55.85% | -40.46% | -258.29% | -49.54% | -6.56% | |
| Total Shareholder Return | -3.19% | -55.85% | -40.46% | -258.29% | -49.54% | -6.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.